Surgify Medical
Private Company
Total funding raised: $12.5M
Overview
Surgify Medical is a private, commercial-stage medical device innovator focused on revolutionizing bone surgery. Its core technology, the Surgify Halo™, utilizes controlled ultrasonic energy to cut bone while preserving surrounding soft tissues, aiming to reduce surgical complications and improve patient outcomes. The company has launched its product in the United States and internationally, positioning itself in the large and growing global orthopedic surgery market. Surgify's value proposition centers on enhancing surgical precision and safety, which could lead to shorter operation times and reduced healthcare costs.
Technology Platform
Ultrasonic bone surgery technology (Surgify Halo™) that uses controlled ultrasonic vibrations to cut bone selectively while preserving surrounding soft tissues, aiming to reduce thermal damage and improve surgical precision.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Surgify competes in the advanced energy-based surgical device segment against traditional mechanical tools (saws, drills) from giants like Stryker and Johnson & Johnson, as well as other advanced technologies like piezoelectric devices and advanced electrocautery. Its differentiation lies in the specific safety profile of its ultrasonic, tissue-selective cutting action.